About the European hESC Registry
The European Human Embryonic Stem Cell Registry (hESCreg) is funded as a Specific Support Action under the ‘Life Sciences, Genomics, and Biotechnology for Human Health’ Priority within the 6th Framework Programme for Research and Technological Development of the European Commission. The Project commenced operations in April 2007 and has an envisaged duration of 3 years.
Dr. Anna Veiga, from the Barcelona Stem Cell Bank at the Center of Regenerative Medicine in Barcelona (CMRB), and Joeri Borstlap, from the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) located at the Charité university hospital in Berlin, jointly co-ordinate the registry. Dr. Glyn Stacey from the UK Stem Cell Bank at the National Institute of Biological Standards and Control and Dr. Andreas Kurtz, also from the BCRT, are lead partners of the registry.
A Scientific Advisory Board of recognized specialists from the field defines, implements and monitors eligibility criteria for the listing of hESCs in order to guarantee the highest quality of the information provided. A Steering Committee of currently 12 partners, who also act as national contacts, forms the link between the local hESC research communities and provides updated information on scientific progress and on new cell lines to the registry.